These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9457098)
1. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Peterson JC; Spence JD Lancet; 1998 Jan; 351(9098):263. PubMed ID: 9457098 [No Abstract] [Full Text] [Related]
2. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go? Spence JD Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038 [TBL] [Abstract][Full Text] [Related]
3. A statement of homocyst(e)ine and cardiovascular disease. Heart and Stroke Foundation of Canada Can J Cardiol; 2001 Jul; 17(7):763-6. PubMed ID: 11515496 [No Abstract] [Full Text] [Related]
4. Homocyst(e)ine, vitamins and genetic interactions in vascular disease. Malinow MR Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683 [TBL] [Abstract][Full Text] [Related]
5. Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease. Kok FJ Bibl Nutr Dieta; 2001; (55):189-91. PubMed ID: 11125576 [No Abstract] [Full Text] [Related]
6. Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin. Naruszewicz M; Klinke M; Dziewanowski K; Staniewicz A; Bukowska H Metabolism; 2001 Feb; 50(2):131-4. PubMed ID: 11229418 [TBL] [Abstract][Full Text] [Related]
7. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Hackam DG; Peterson JC; Spence JD Am J Hypertens; 2000 Jan; 13(1 Pt 1):105-10. PubMed ID: 10678280 [TBL] [Abstract][Full Text] [Related]
8. Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia. Nallamothu BK; Fendrick AM; Omenn GS Pharmacoeconomics; 2002; 20(7):429-42. PubMed ID: 12093299 [TBL] [Abstract][Full Text] [Related]
9. Homocysteine: update on a new risk factor. Ballal RS; Jacobsen DW; Robinson K Cleve Clin J Med; 1997; 64(10):543-9. PubMed ID: 9385741 [TBL] [Abstract][Full Text] [Related]
10. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. Clarke R; Collins R J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473 [No Abstract] [Full Text] [Related]
11. Genes, greens, and homocysteine. Meleady RA; Mulcahy DA; Graham IM Heart; 1996 Aug; 76(2):103-4. PubMed ID: 8795467 [No Abstract] [Full Text] [Related]
12. [Group B vitamins as new variables related to the cardiovascular risk]. Granieri M; Bellisarii FI; De Caterina R Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726 [TBL] [Abstract][Full Text] [Related]
13. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation). Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA; Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424 [TBL] [Abstract][Full Text] [Related]
14. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate. Henning BF; Zidek W; Riezler R; Graefe U; Tepel M Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667 [TBL] [Abstract][Full Text] [Related]
15. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet. Hallert C; Svensson M; Tholstrup J; Hultberg B Aliment Pharmacol Ther; 2009 Apr; 29(8):811-6. PubMed ID: 19154566 [TBL] [Abstract][Full Text] [Related]
16. [Effect of vitamins A, C, and B group on Hymenolepis nana in white mice]. Baiandina DG; Kovchur VN Med Parazitol (Mosk); 1973; 42(2):156-9. PubMed ID: 4805409 [No Abstract] [Full Text] [Related]
17. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases. Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237 [TBL] [Abstract][Full Text] [Related]